Sleep apnea is the state of constant airway hindrance during sleep, potentially directing towards cardiovascular disease, high blood pressure, weight gain, memory problems, headache, and impotence. Airway hindrance leads to oxygen deficiency. Enlarged carbon dioxide blood levels kindle the brain’s respiratory center to recommence breathing (at times, at a rapid compensatory rate), which arouses the individual or obstructs the sleep cycle. Sleepiness, restless sleep, and tiredness are habitually noticed by victims of sleep apnea. It is one of the frequent disorders which results in poor or troubled quality sleep. It is mostly sourced by breathing breaks or shallow breathing throughout the sleep. To take care of sleep apnea, extensive ranges of therapeutic and diagnostic medical devices are utilized.
North American sleep apnea devices market is expected to rise, as device manufacturers are continuously developing improved tools to increase efficiency, patient compliance, and cost-effectiveness. Technological advances in mask designs, improved designs of CPAP, Bi-level, APAP devices, and enhanced support services for PAP (Positive Airway Pressure) device users is expected to stimulate the growth of this market.
The primary drivers of this industry include growing awareness about hypertension, stroke, and sophisticated healthcare infrastructure and Type II mature onset diabetes. These reasons are expected to drive the industry over the forecast period. Initialisation of advanced technology such as new and competent treatment diagnosis and methodologies has improved patient result over the past few years. Sleep apnea equipment demands are picking up owing to increasing occurrences of stress & depression, obesity, long working hours, high incidences of diabetes and rise in anxiety levels have resulted in numerous sleep disorders. Requirements in developed countries have got enormous momentum as this industry is in initial stage owing to the urban healthcare infrastructure and high consciousness about these devices. These devices are expected to witness technological advancements that will result in the expansion of efficient therapeutic and diagnostic platforms. Sleep disorders obstruct the quality of life and cause lss of output and efficiency of an individual. Many of these cases are undiagnosed owing to lack of consciousness regarding the effects. Undiagnosed sleep apnea results in deterioration of several health conditions such as stroke, hypertension, heart diseases diabetes, and others. Hence, identification of this condition is necessary to uphold a productive and healthy lifestyle.
Post diagnosis based on the strictness of the condition the patient is suggested to use some therapeutic devices such as constructive airway pressure devices, oral appliances, oxygen concentrator, etc. Home sleep testing and sleep laboratory testing describes the two modes of diagnosis. Currently, home sleep testing with its compact and user-friendly devices is preferred over the conventional equipment, which is owing to relieve high levels and effortlessness in the handling of these devices. The main factors contributing towards the rise of these devices are constant product alterations, the introduction of novel technologies and growing awareness of sleep apnea. On the opposite side, the high price of diagnostic procedures, a need of patient obedience with therapeutic devices and a lot of discomfort levels is some of the reasons that might hinder the expansion of the industry.
By end use, the market can be segregated into therapeutic and diagnostic devices. Both the segments have seen steady growth over the last few years, and it is expected that both the parts will see a rapid increase in their use over the forecast period owing to increasing awareness levels about these devices across the world. By devices, the market can be segregated into PAP (Positive Airway Pressure) device, PSG devices (Polysomnography), actigraphy systems, humidifiers, oxygen equipment, adaptive servo-ventilation systems, oral appliances and screening devices. Positive Airway Pressure Devices segment is expected to capture maximum revenue over the forecast period owing to its extensive utilization. By the geographical region, the market can be segregated into Asia Pacific, North America, Europe and Rest of the World. North America is expected to capture maximum revenue over the forecast period owing to the high occurrence of sleep apnea coupled with increasing side-effects of urban lifestyle. North Americais followed by Europe due to increasing technological advancements in sleep apnea treatment combined with rising occurrence of cardiology disorders. Asia Pacific is expected to be the rapid growing market over the forecast period owing to rapid urbanization in the countries of Asia Pacific.
The key players in the market are Curative Medical, Inc, Paykel Healthcare, Ltd., DeVilbiss Healthcare, Weinmann Medical Devices GmbH & Co. KG, Natus Medical Incorporated, Itamar Medical, Ltd, Global Medical Holdings, Philips Healthcare, ResMed and, Compumedics Limited. The companies are giving CPAP devices. Some CPAP devices decrease air pressure upon breath to raise patient comfort, though such a trait is standard by bi-level PAP systems (positive airway pressure) anticipated for more sleep receptive patients or those with previous respiratory issues. Automated PAP (APAP) systems endlessly adjust air pressure to hold changeable patient breathing and decrease resistive pressure throughout exhalation. The market is not much fragmented, but there is lack of standardization across the market.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.